What is ARWR's dilution risk score?

ARWR has a latest available DilutionScore record of 13/100, categorized as low dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for ARWR, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for ARWR?

DilutionWatch tracks 25 SEC filing types for ARWR including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect ARWR shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For ARWR, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for ARWR tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for ARWR. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

ARWR Dilution Risk Score: 13/100 (LOW)

Score Breakdown

📋 Offering Ability

22

💰 Cash Runway

0

📊 Float Risk

2

⚠️ Warrant Exposure

15

🔄 Convertible Debt

35

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 7%

🔁 Convertible Conversion model 15%

• Convertible debt present: 6.4% potential dilution

🔔 Track ARWR — Get forecast alerts →

Market Data

Market Cap$10.97B

Shares Outstanding141.25M

Float122.78M

Cash$1.66B

Debt$1.38B

Short InterestN/A

Institutional Holdings

QoQ: ↑ 25.8% shares (2026Q1 vs prior)

441 institutional holders · 152.53M shares

#1 Avoro Capital Advisors LLC 21.32M shares

#2 BlackRock, Inc. 18.16M shares

#3 VANGUARD CAPITAL MANAGEMENT LLC 12.06M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest9.66M

Days to Cover3.9

% of Float7.9%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-06-30

xbrl XBRL WARRANT 2025-09-30

4 INSIDER TRANSACTION 2026-03-09

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual ARWR Dilution Snapshot

Arrowhead Pharmaceuticals, Inc. (ARWR) has a DilutionScore of 13/100, rated Low dilution risk. Score date: August 28, 2026.

Stored outstanding warrants: 917,441.
Recent SEC activity tracked for ARWR: xbrl on 2026-06-30; 4 on 2026-03-09; xbrl on 2025-09-30.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.